These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8112829)

  • 1. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
    Moilanen E; Kirkkola AL; Kankaanranta H; Nieminen MM; Vapaatalo H
    Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
    Komatsu H; Amano M
    Int J Immunopharmacol; 1997; 19(11-12):661-7. PubMed ID: 9669206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
    Bozza PT; Payne JL; Goulet JL; Weller PF
    J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
    J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP; McColl SR; Braquet P; Borgeat P
    Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor.
    Shindo K; Koide K; Fukumura M
    Thorax; 1997 Dec; 52(12):1024-9. PubMed ID: 9516893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.
    Hilger RA; Köller M; König W
    Inflammation; 1996 Feb; 20(1):57-70. PubMed ID: 8926049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes.
    Hirafuji M; Shinoda H
    J Lipid Mediat; 1991 Nov; 4(3):347-51. PubMed ID: 1662550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of calcimycin-induced stimulation of cytosolic calcium in human PMN by a LTB4 receptor antagonist.
    Heckenberger R; Schrör K
    Eicosanoids; 1992; 5 Suppl():S23-5. PubMed ID: 1333252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium ionophore potentiates chemotactic peptide and platelet activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
    Tanizawa H; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):45-9. PubMed ID: 2169061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients.
    Shindo K; Koide K; Fukumura M
    Eur Respir J; 1998 May; 11(5):1098-104. PubMed ID: 9648962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.
    Sperling RI; Benincaso AI; Knoell CT; Larkin JK; Austen KF; Robinson DR
    J Clin Invest; 1993 Feb; 91(2):651-60. PubMed ID: 8381824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
    Zhou W; Javors MA; Olson MS
    Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
    Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
    J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
    Williams JD; Lee TH; Lewis RA; Austen F
    J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils.
    McIntyre TM; Reinhold SL; Prescott SM; Zimmerman GA
    J Biol Chem; 1987 Nov; 262(32):15370-6. PubMed ID: 2824456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T; Fogh K; Kragballe K
    Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of leukotriene B4 synthesis in canine polymorphonuclear leukocytes.
    Amalsadvala TM; Vaughn DM
    Prostaglandins Leukot Essent Fatty Acids; 1992 Apr; 45(4):283-8. PubMed ID: 1318548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.